Your browser doesn't support javascript.
loading
Multiple Mechanistic Models Reveal the Neuroprotective Effects of Diterpene Ginkgolides against Astrocyte-Mediated Demyelination via the PAF-PAFR Pathway.
Wang, Tuan-Jie; Wu, Zi-Yin; Yang, Chun-Hua; Cao, Liang; Wang, Zhen-Zhong; Cao, Ze-Yu; Yu, Ming-Yang; Zhao, Meng-Ru; Zhang, Chen-Feng; Liu, Wen-Jun; Zhao, Bin-Jiang; Shang, Xue-Qi; Feng, Yu; Wang, Hui; Deng, Li-Li; Xiao, Bao-Guo; Guo, Hong-Yan; Xiao, Wei.
Afiliação
  • Wang TJ; Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu 210023, P. R. China.
  • Wu ZY; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Yang CH; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Cao L; National Engineering Research Center for Beijing Biochip Technology, Beijing 102206, P. R. China.
  • Wang ZZ; CapitalBio Corporation, Beijing 102206, P. R. China.
  • Cao ZY; Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu 210023, P. R. China.
  • Yu MY; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Zhao MR; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Zhang CF; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Liu WJ; Key Laboratory of Standardization of Chinese Medicines, Ministry of Education Institute of Chinese Materia Medica of Shanghai, University of Traditional Chinese Medicine, Shanghai 201203, P. R. China.
  • Zhao BJ; Key Laboratory of Standardization of Chinese Medicines, Ministry of Education Institute of Chinese Materia Medica of Shanghai, University of Traditional Chinese Medicine, Shanghai 201203, P. R. China.
  • Shang XQ; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Feng Y; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Wang H; State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu 222001, P. R. China.
  • Deng LL; National Engineering Research Center for Beijing Biochip Technology, Beijing 102206, P. R. China.
  • Xiao BG; CapitalBio Corporation, Beijing 102206, P. R. China.
  • Guo HY; National Engineering Research Center for Beijing Biochip Technology, Beijing 102206, P. R. China.
  • Xiao W; CapitalBio Corporation, Beijing 102206, P. R. China.
Am J Chin Med ; 50(6): 1565-1597, 2022.
Article em En | MEDLINE | ID: mdl-35902245
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Fármacos Neuroprotetores / Acidente Vascular Cerebral / Diterpenos / AVC Isquêmico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Fármacos Neuroprotetores / Acidente Vascular Cerebral / Diterpenos / AVC Isquêmico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article